Thermo Fisher Scientific Inc (TMO) Shares are Down -0.77%

Thermo Fisher Scientific Inc (TMO) : During the past 4 weeks, traders have been relatively bearish on Thermo Fisher Scientific Inc (TMO), hence the stock is down -3.89% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.27% relative to the S&P 500. The 4-week change in the price of the stock is -4.02% and the stock has fallen -0.77% in the past 1 week.

The stock has recorded a 20-day Moving Average of 2.01% and the 50-Day Moving Average is 1.69%.The 200 Day SMA reached 5.44%. Thermo Fisher Scientific, Inc. has dropped 1.21% during the last 3-month period . Year-to-Date the stock performance stands at 6.8%.


Thermo Fisher Scientific Inc (NYSE:TMO): After opening at $151.23, the stock dipped to an intraday low of $150.67 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $151.84 and the buying power remained strong till the end. The stock closed at $151.18 for the day, a gain of 0.15% for the day session. The total traded volume was 1,104,239. The stocks close on the previous trading day was $150.95.

Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.